These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8358536)

  • 1. Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.
    MacGregor DG; Stone TW
    Br J Pharmacol; 1993 Jun; 109(2):316-21. PubMed ID: 8358536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of kainate-induced excitotoxicity by a purine analogue.
    MacGregor DG; Stone TW
    Neuroreport; 1992 Jun; 3(6):536-8. PubMed ID: 1327268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
    MacGregor DG; Miller WJ; Stone TW
    Br J Pharmacol; 1993 Sep; 110(1):470-6. PubMed ID: 8220909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of purine protection against kainate-induced increase in hippocampal [3H]-PK11195 binding.
    Miller WJ; MacGregor DG; Stone TW
    Brain Res Bull; 1994; 34(2):133-6. PubMed ID: 8044687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus.
    MacGregor DG; Jones PA; Maxwell WL; Graham DI; Stone TW
    Brain Res; 1996 Jun; 725(1):115-20. PubMed ID: 8828594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicity.
    Macgregor DG; Stone TW
    Brain Res; 1994 May; 644(2):339-42. PubMed ID: 8050046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists.
    MacGregor DG; Graham DI; Stone TW
    Exp Neurol; 1997 Nov; 148(1):110-23. PubMed ID: 9398454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine.
    Fredholm BB; Jonzon B; Lindgren E
    Acta Physiol Scand; 1984 Sep; 122(1):55-9. PubMed ID: 6095597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue.
    Fredholm BB; Jonzon B; Lindgren E
    Acta Physiol Scand Suppl; 1983; 515():7-10. PubMed ID: 6578673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by an adenosine analogue against kainate-induced extrahippocampal neuropathology.
    MacGregor DG; Graham DI; Jones PA; Stone TW
    Gen Pharmacol; 1998 Aug; 31(2):233-8. PubMed ID: 9688465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine.
    Fastbom J; Fredholm BB
    Acta Physiol Scand; 1985 Sep; 125(1):121-3. PubMed ID: 2864783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia protects against the neurotoxicity of kainic acid.
    Pohle W; Rauca C
    Brain Res; 1994 May; 644(2):297-304. PubMed ID: 8050040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension.
    Connick JH; Stone TW
    Neurosci Lett; 1989 Jun; 101(2):191-6. PubMed ID: 2771165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus.
    MacGregor DG; Higgins MJ; Jones PA; Maxwell WL; Watson MW; Graham DI; Stone TW
    Brain Res; 1996 Jul; 727(1-2):133-44. PubMed ID: 8842391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A purine analogue reduces kainate neurotoxicity in vivo.
    MacGregor DG; Chishti SK; Stone TW
    Biochem Soc Trans; 1993 Feb; 21(1):12S. PubMed ID: 8383603
    [No Abstract]   [Full Text] [Related]  

  • 16. The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade.
    Allgaier C; Hertting G; Kügelgen OV
    Br J Pharmacol; 1987 Feb; 90(2):403-12. PubMed ID: 3103806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity.
    Veiga S; Azcoitia I; Garcia-Segura LM
    J Neurosci Res; 2005 Apr; 80(1):129-37. PubMed ID: 15696538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels.
    Plamondon H; Blondeau N; Heurteaux C; Lazdunski M
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1296-308. PubMed ID: 10598933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists.
    Berg M; Bruhn T; Johansen FF; Krogsgaard-Larsen P; Diemer NH
    Acta Neuropathol; 1991; 81(3):255-60. PubMed ID: 1829311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats.
    Mathôt RA; Van den Aarsen BC; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1995 Apr; 273(1):405-14. PubMed ID: 7714796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.